FDA Mission Should Not Include Rx Cost-Effectiveness, Rep. Allen Says
Executive Summary
FDA is not the appropriate agency to oversee comparative research involving drugs and devices, Rep. Tom Allen (D-Maine) says
You may also be interested in...
CMS To Issue Clinical Evidence Policy Paper In August
The Centers for Medicare & Medicaid Services will issue a position paper in August outlining ideas for improving the quality of clinical evidence, CMS Chief Medical Officer Sean Tunis, MD, said
CMS To Issue Clinical Evidence Policy Paper In August
The Centers for Medicare & Medicaid Services will issue a position paper in August outlining ideas for improving the quality of clinical evidence, CMS Chief Medical Officer Sean Tunis, MD, said
CMS, Industry To Debate “Practical” Trials On July 20 Audio Conference
The benefits and pitfalls of "practical clinical trials" for drugs and devices will be debated during a July 20 Drug & Device Dialogue 1audio conference